Literature DB >> 34003913

Low Luminance Visual Acuity and Low Luminance Deficit in Choroideremia and RPGR-Associated Retinitis Pigmentosa.

Laura J Wood1,2, Jasleen K Jolly1,2, Amandeep S Josan1,2, Thomas M W Buckley2, Robert E MacLaren1,2.   

Abstract

Introduction: Choroideremia and RPGR-associated retinitis pigmentosa (RP) are two distinct inherited rod-cone degenerations, where good visual acuity (VA) is maintained until late disease stages, limiting its usefulness as a disease marker. Low luminance VA and low luminance deficit (standard VA minus low luminance VA) may be more sensitive visual function measures.
Methods: Standard VA was obtained using Early Treatment Diabetic Retinopathy Study letter charts (Precision Vision, Bloomington, IL, USA). Low luminance VA was assessed using a 2.0-log unit neutral density filter, with the same chart setup, without formal dark adaptation. Mean central retinal sensitivity was assessed using MAIA microperimetry (Centervue SpA, Padova, Italy). Optical coherence tomography imaging was attained with Heidelberg Eye Explorer software (Heidelberg Engineering, Heidelberg, Germany).
Results: Twenty-four male participants with confirmed pathogenic RPGR mutations, 44 male participants with confirmed pathogenic CHM mutations, and 62 age-matched controls underwent clinical assessment prior to clinical trial recruitment. Low luminance VA was significantly reduced in both disease groups compared to controls. The low luminance deficit correlated with microperimetry retinal sensitivity and ellipsoid zone width. Eleven participants with moderate VA had poor low luminance VA (subsequently a large low luminance deficit), no detectable microperimetry sensitivity, and severely constricted ellipsoid zone widths. Conclusions: Low luminance VA and subsequently low luminance deficit are useful markers of central macular visual function in both choroideremia and RPGR-associated RP, when standard VA is preserved. Translational Relevance: Low luminance visual acuity and low luminance deficit are useful vision measures in two distinct rod-cone degenerations and may be useful in other retinal degenerations.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34003913      PMCID: PMC7900861          DOI: 10.1167/tvst.10.2.28

Source DB:  PubMed          Journal:  Transl Vis Sci Technol        ISSN: 2164-2591            Impact factor:   3.283


  35 in total

1.  Repeatability and intercorrelations of standard vision tests as a function of age.

Authors:  J E Lovie-Kitchin; B Brown
Journal:  Optom Vis Sci       Date:  2000-08       Impact factor: 1.973

2.  Impact of cataract surgery on vision-related life performances: the usefulness of Real-Life Vision Test for cataract surgery outcomes evaluation.

Authors:  W Ni; X Li; Z Hou; H Zhang; W Qiu; W Wang
Journal:  Eye (Lond)       Date:  2015-08-14       Impact factor: 3.775

Review 3.  Low luminance visual acuity as a clinical measure and clinical trial outcome measure: a scoping review.

Authors:  Laura J Wood; Jasleen K Jolly; Thomas Mw Buckley; Amandeep S Josan; Robert E MacLaren
Journal:  Ophthalmic Physiol Opt       Date:  2021-01-06       Impact factor: 3.117

4.  Choroideremia: variability of clinical and electrophysiological characteristics and first report of a negative electroretinogram.

Authors:  Agnes B Renner; Ulrich Kellner; Elke Cropp; Markus N Preising; Ian M MacDonald; José A J M van den Hurk; Frans P M Cremers; Michael H Foerster
Journal:  Ophthalmology       Date:  2006-08-28       Impact factor: 12.079

5.  Test-retest repeatability of microperimetry in patients with retinitis pigmentosa caused by mutations in RPGR.

Authors:  Thomas M W Buckley; Jasleen K Jolly; Moreno Menghini; Laura J Wood; Anika Nanda; Robert E MacLaren
Journal:  Clin Exp Ophthalmol       Date:  2020-04-27       Impact factor: 4.207

Review 6.  Gene therapy for RPE65-related retinal disease.

Authors:  Virginia Miraldi Utz; Razek Georges Coussa; Fares Antaki; Elias I Traboulsi
Journal:  Ophthalmic Genet       Date:  2018-10-18       Impact factor: 1.803

7.  A Qualitative and Quantitative Assessment of Fundus Autofluorescence Patterns in Patients With Choroideremia.

Authors:  Jasleen K Jolly; Thomas L Edwards; Jonathan Moules; Markus Groppe; Susan M Downes; Robert E MacLaren
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-08-01       Impact factor: 4.799

8.  Gene therapy for the treatment of X-linked retinitis pigmentosa.

Authors:  Cristina Martinez-Fernandez De La Camara; Anika Nanda; Anna Paola Salvetti; M Dominik Fischer; Robert E MacLaren
Journal:  Expert Opin Orphan Drugs       Date:  2018-02-27       Impact factor: 0.694

9.  Predicting vision gains with anti-VEGF therapy in neovascular age-related macular degeneration patients by using low-luminance vision.

Authors:  Ronald E P Frenkel; Howard Shapiro; Ivaylo Stoilov
Journal:  Br J Ophthalmol       Date:  2015-11-05       Impact factor: 4.638

10.  Interpreting MAIA Microperimetry Using Age- and Retinal Loci-Specific Reference Thresholds.

Authors:  Jason Charng; Paul G Sanfilippo; Mary S Attia; Monika Dolliver; Sukanya Arunachalam; Avenell L Chew; Evan N Wong; David A Mackey; Fred K Chen
Journal:  Transl Vis Sci Technol       Date:  2020-06-18       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.